Literature DB >> 9018149

Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species.

T Ito1, Y Suzuki, L Mitnaul, A Vines, H Kida, Y Kawaoka.   

Abstract

Despite their uniform ability to bind to oligosaccharide-containing terminal sialic acids, influenza A viruses show differences in receptor specificity. To test whether agglutination of erythrocytes from different animal species could be used to assess the receptor specificity of influenza A viruses, we determined the agglutinating activities of a range of virus strains, including those with known receptor specificities, using erythrocytes from seven animal species. All equine and avian viruses, including those known to recognize N-acetyl and N-glycolyl sialic acid linked to galactose by the alpha2,3 linkage (NeuAc alpha2,3Gal and NeuGc alpha2,3Gal), agglutinated erythrocytes from all of the animal species tested (chickens, ducks, guinea pigs, humans, sheep, horses, and cows). The human viruses, including those known to preferentially recognize NeuAc alpha2,6Gal, agglutinated all but the horse and cow erythrocytes. Fluorescence-activated cell sorting analysis of erythrocytes using linkage-specific lectins [Sambucus nigra agglutinin for sialic acid (SA) alpha2,6Gal and Maackia amurensis agglutinin for SA alpha2,3Gal] showed that both cow and horse erythrocytes contain a large amount of SA alpha2,3Gal-, but virtually no SA2,6Gal-specific lectin-reactive oligosaccharides on the cell surface, while human and chicken erythrocytes contained both types of oligosaccharides. Considering that the majority (>93%) of sialic acid in horse and cow erythrocytes is of the N-glycolyl type, our results suggest that viruses able to agglutinate these erythrocytes (i.e., avian and equine viruses) recognize NeuGc alpha2,3Gal. These findings also show that agglutinating assays with erythrocytes from different animal species would be useful in characterizing the receptor specificity of influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018149     DOI: 10.1006/viro.1996.8323

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  118 in total

1.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

2.  Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host.

Authors:  Ruth Harvey; Andrew C R Martin; Maria Zambon; Wendy S Barclay
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Mitch Phillips; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

4.  Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation.

Authors:  Jeong-Hyun Nam; Eun-Ha Kim; Daesub Song; Young Ki Choi; Jeong-Ki Kim; Haryoung Poo
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  Residue Y161 of influenza virus hemagglutinin is involved in viral recognition of sialylated complexes from different hosts.

Authors:  Minxiu Wang; Donna M Tscherne; Christopher McCullough; Michael Caffrey; Adolfo García-Sastre; Lijun Rong
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs.

Authors:  Guohua Yang; Shoujun Li; Sherry Blackmon; Jianqiang Ye; Konrad C Bradley; Jim Cooley; Dave Smith; Larry Hanson; Carol Cardona; David A Steinhauer; Richard Webby; Ming Liao; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2013-09-01       Impact factor: 3.891

7.  Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.

Authors:  Erich Hoffmann; Aleksandr S Lipatov; Richard J Webby; Elena A Govorkova; Robert G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

8.  Cross-Species Infectivity of H3N8 Influenza Virus in an Experimental Infection in Swine.

Authors:  Alicia Solórzano; Emanuela Foni; Lorena Córdoba; Massimiliano Baratelli; Elisabetta Razzuoli; Dania Bilato; María Ángeles Martín del Burgo; David S Perlin; Jorge Martínez; Pamela Martínez-Orellana; Lorenzo Fraile; Chiara Chiapponi; Massimo Amadori; Gustavo del Real; María Montoya
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

9.  Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells.

Authors:  Rachel E Owen; Eriko Yamada; Catherine I Thompson; Louisa J Phillipson; Clare Thompson; Elizabeth Taylor; Maria Zambon; Helen M I Osborn; Wendy S Barclay; Persephone Borrow
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

10.  Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.

Authors:  Yasuhiro Abe; Emi Takashita; Kanetsu Sugawara; Yoko Matsuzaki; Yasushi Muraki; Seiji Hongo
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.